Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.

CD55 Antikörper (AA 51-150)

CD55 Reaktivität: Human WB Wirt: Maus Monoclonal D5FF2 unconjugated

Produktnummer ABIN7090997

Datenblatt (PDF)

Target Alle CD55 Antikörper anzeigen

CD55 (Complement Decay-Accelerating Factor (CD55))
Bindungsspezifität
15

9

5

3

3

3

3

2

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1
AA 51-150
Reaktivität
123

32

7

4

4

4

3

2

2

2
Human
Wirt
86

64

6

5

2

1

1
Maus
Passende Sekundärantikörper
Klonalität
99

64

2
Monoklonal
Konjugat
78

16

14

11

5

4

3

2

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1
Dieser CD55 Antikörper ist unkonjugiert
Applikation
92

89

44

33

29

24

17

15

14

14

8

4

4

3

3

1

1

1

1
Western Blotting (WB)

Homologie

Human

Immunogen

KLH conjugated synthetic peptide derived from human CD55

Klon

D5FF2

Isotyp

IgG1

Top Product

Discover our top product CD55 Primärantikörper
anti-Complement Decay-Accelerating Factor (CD55) (AA 35-134) antibody
CD55 Reaktivität: Human WB, ELISA, PLA Wirt: Maus Monoclonal 1G3 unconjugated

anti-Complement Decay-Accelerating Factor (CD55) (AA 35-285) antibody
CD55 Reaktivität: Human WB, ELISA, IHC (fro), ICC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated

anti-Complement Decay-Accelerating Factor (CD55) (AA 40-300) antibody
CD55 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated

anti-Complement Decay-Accelerating Factor (CD55) (AA 51-79) antibody
CD55 Reaktivität: Human FACS, WB, IHC, IF, ELISA Wirt: Kaninchen Polyclonal unconjugated

anti-Complement Decay-Accelerating Factor (CD55) (AA 35-134) antibody
CD55 Reaktivität: Human WB, IF, ELISA Wirt: Maus Monoclonal 1D7 unconjugated

anti-Complement Decay-Accelerating Factor (CD55) (Center) antibody
CD55 Reaktivität: Human WB, IF, ICC Wirt: Kaninchen Polyclonal unconjugated

anti-Complement Decay-Accelerating Factor (CD55) antibody
CD55 Reaktivität: Human, Non-Human Primate FACS, WB, IP, IHC (p) Wirt: Maus Monoclonal MEM-118 unconjugated

anti-Complement Decay-Accelerating Factor (CD55) (AA 254-372) antibody
CD55 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated

anti-Complement Decay-Accelerating Factor (CD55) (AA 35-126) antibody
CD55 Reaktivität: Human IHC, IF, ELISA Wirt: Kaninchen Polyclonal unconjugated

anti-Complement Decay-Accelerating Factor (CD55) antibody (Biotin)
CD55 Reaktivität: Human, Non-Human Primate FACS, WB, IP, IHC (p) Wirt: Maus Monoclonal MEM-118 Biotin

Applikationshinweise

WB 1:300-5000

Beschränkungen

Nur für Forschungszwecke einsetzbar
Konzentration

0.5 μg/μL

Buffer

0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Konservierungsmittel

ProClin

Vorsichtsmaßnahmen

This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung

4 °C,-20 °C

Informationen zur Lagerung

Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Haltbarkeit

12 months
Target

CD55 (Complement Decay-Accelerating Factor (CD55))

Andere Bezeichnung

CD55 (CD55 Produkte)

Hintergrund

Synonyms: CD 55, CD55 antigen, CD55 Cromer blood group system, CD55 Molecule, CD55 Molecule, decay accelerating factor for complement (Cromer blood group), Cd55a, Complement decay accelerating factor, Complement decay-accelerating factor, Complement decay-accelerating factor, GPI-anchored, CR, CROM, Cromer Blood Group antigen, Cromer blood group system, DAF, Daf-GPI, DAF_HUMAN, Daf1, Dcay accelerating factor for complement (CD55, Cromer blood group system), Decay accelarating factor 1, isoform CRA_a, Decay accelerating factor (GPI-form), Decay Accelerating Factor for Complement, Decay accelerating factor GPI-form, Decay accelerating factor soluble-form, GPI-DAF, TC.
Background: This protein recognizes C4b and C3b fragments that condense with cell-surface hydroxyl or amino groups when nascent C4b and C3b are locally generated during C4 and c3 activation. Interaction of daf with cell-associated C4b and C3b polypeptides interferes with their ability to catalyze the conversion of C2 and factor B to enzymatically active C2a and Bb and thereby prevents the formation of C4b2a and C3bBb, the amplification convertases of the complement cascade.

Gen-ID

1604

UniProt

P08174

Pathways

Komplementsystem, Regulation of Leukocyte Mediated Immunity